Clinical trial
Investigation of Mass Balance of the Test Drug and Major Metabolites
NCT00432302 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00432302 |
|---|---|
| Title | Investigation of Mass Balance of the Test Drug and Major Metabolites |
| Official title | Investigation of Mass Balance and Major Metabolites After Administration of 28 mg Radiolabeled ZK 219477 in Patients With Solid Tumor in an Open-label, Non Randomized Design |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | Sagopilone (BAY 86-5302, ZK 219477) |
| Enrollment | 7 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Feb 7, 2007 |
| Last update posted | Dec 14, 2015 |
| Countries | Belgium |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: